Paloma Partners Management CO Chimerix Inc Transaction History

Paloma Partners Management CO

  • $3.28 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$1.79 - $3.12 $49,583 - $86,424
-27,700 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$2.24 - $3.9 $62,048 - $108,030
27,700 New
27,700 $71,000
Q3 2018

Nov 14, 2018
SELL
$3.58 - $4.9 $47,972 - $65,660
-13,400 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$4.43 - $5.14 $59,361 - $68,876
13,400 New
13,400 $64,000

Others Institutions Holding CMRX

# of Institutions
81
Shares Held
36.8M
Call Options Held
72.2K
Put Options Held
169K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email